Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly, prescribed at DermaVue clinics across Kerala and Tamil Nadu, India, for physician-supervised medical weight loss
Brain Sci 13:784
Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, Yoshikawa S, Tsuchida T, Kawabata Y, Tamaki K: Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan
Some observational data suggest weight loss from GLP-1 use may indirectly improve metabolic markers in patients with both Hashimoto's and obesity
Heat application is known to reduce muscle spasms
It has the capacity to regenerate itself from only one fourth of its mass if an illness warrants a partial removal